Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT02638090 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02638090
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-22
- Primary completion
- 2024-01-21
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.